000 | 01912 a2200529 4500 | ||
---|---|---|---|
005 | 20250516142406.0 | ||
264 | 0 | _c20131231 | |
008 | 201312s 0 0 eng d | ||
022 | _a1748-717X | ||
024 | 7 |
_a10.1186/1748-717X-8-72 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMuecke, Ralph | |
245 | 0 | 0 |
_aImpact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology--a subgroup analysis of a multicenter, phase III trial. _h[electronic resource] |
260 |
_bRadiation oncology (London, England) _cMar 2013 |
||
300 |
_a72 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aCarcinoma _xblood |
650 | 0 | 4 |
_aDiarrhea _xetiology |
650 | 0 | 4 | _aDietary Supplements |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRadiotherapy Planning, Computer-Assisted |
650 | 0 | 4 |
_aRadiotherapy, Adjuvant _xadverse effects |
650 | 0 | 4 |
_aSelenium _xblood |
650 | 0 | 4 |
_aSodium Selenite _xtherapeutic use |
650 | 0 | 4 |
_aUterine Cervical Neoplasms _xblood |
700 | 1 | _aMicke, Oliver | |
700 | 1 | _aSchomburg, Lutz | |
700 | 1 | _aBuentzel, Jens | |
700 | 1 | _aGlatzel, Michael | |
700 | 1 | _aBaaske, Dieter | |
700 | 1 | _aBerndt-Skorka, Regina | |
700 | 1 | _aPrott, Franz J | |
700 | 1 | _aReichl, Berthold | |
700 | 1 | _aKisters, Klaus | |
700 | 1 | _aSchaefer, Ulrich | |
700 | 1 | _aHuebner, Jutta | |
700 | 1 | _aEich, Hans Th | |
700 | 1 | _aKundt, Guenther | |
700 | 1 | _aAdamietz, Irenaeus A | |
773 | 0 |
_tRadiation oncology (London, England) _gvol. 8 _gp. 72 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1748-717X-8-72 _zAvailable from publisher's website |
999 |
_c22616931 _d22616931 |